July 21 (Reuters) – * Redhill Biopharma gets additional U.S. patent covering
RHB-105 ahead of confirmatory stage III study for H. Pylori
* Gotten notice of allowance for extra U.S. Patent
covering RHB-105, expected to be valid up until 2034 once granted
Source text for Eikon:
( Bengaluru Newsroom; +1 646 223 8780).